Login or sign up
For business

BioIntervene

4.1Β· 9 reviews
Average ratingGreat
4.1/ 5

Based on 9 reviews

533%
444%
322%
20%
10%
Ask AI

Ask Trustburn about BioIntervene

Based on 9 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

David Ochoa
Reviews 1

I recently purchased some products from a company called BioIntervene and I am extremely satisfied with my experience. The website was easy to navigate and the ordering process was quick and efficient. The products arrived promptly and were exactly what I was expecting. I would definitely buy from them again.

Thomas Weis
Reviews 1

I had a really positive experience with BioIntervene. The customer service representatives were friendly and knowledgeable, and they were able to answer all of my questions. The products that I received were of high quality and exceeded my expectations. I would definitely recommend BioIntervene to others. Keep up the good work!

Kerry Pietras
Reviews 1

I recently had the pleasure of purchasing some products from BioIntervene and I must say, I am extremely impressed. The quality of their products is exceptional and their customer service is top-notch. I wouldn't hesitate to recommend BioIntervene to anyone in need of their services.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website β€” a simple way to convert your visitors into customers.

Get the widget for your site →

About BioIntervene

BioIntervene, Inc. is a preclinical-stage biopharmaceutical company committed to the discovery and development of effective and non-addictive medicines for chronic pain and other chronic inflammatory and neurodegenerative disorders. The Company was founded in 2014 based on insights from research at Saint Louis University and the National Institutes of Health (NIH). BioIntervene’s founding team has pioneered the understanding of adenosine A3 receptor biology, with a focus on developing first-in-class, selective adenosine A3 receptor agonists.